USCOM in Newly Diagnosed FGR Cases

Part of paid clinical trials in New York, New York.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT06343051
Status
Recruiting
Apply to this trial

Conditions

  • Fetal Growth Restriction
  • USCOM

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • USCOM — DEVICE
    Device that measures how much blood is being pumped in and out of the heart.

Study Details

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.

Key Dates

Start date
Jul 2, 2024
Status verified
Jul 2024
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Fetal Growth Restriction diagnosed > 27w6d gestation
    Patients with a new diagnosis of fetal growth restriction after 27 weeks 6 days' gestation.

Primary Outcome Measure

Systemic vascular resistance obtained from USCOM [ Time Frame: every 2-4 weeks at time of prenatal ultrasound, until the end of pregnancy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mount Sinai HospitalNew YorkNew York10029
Nicola F Tavella, MPH
[email protected]
2122413888
Rachel J Meislin (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Mount Sinai Hospital· New York, NY

Related Studies